Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wijermans

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Future Oncology (London, England)|March 25, 2006
Epigenetic therapy with decitabine for myelodysplasia and leukemiaP Wijermans, M Lübert
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1980
Influence of adult thymectomy on immunocompetence in patients with myasthenia gravisP Wijermans, H J Oosterhuis, G C Astaldi, et al.
The Netherlands Journal of Medicine|March 7, 2013
A survey on diagnostic methods and treatment strategies used in patients with Waldenström's macroglobulinaemia in The NetherlandsS Klodzinska, J M I Vos, M J Kersten, et al.
Clinical and Experimental Immunology|January 1, 1983
Low beta-adrenergic receptor concentration on human thymocytesR J van de Griend, A Astaldi, P Wijermans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patientsP Wijermans, M Lübbert, G Verhoef, et al.
European Journal of Immunology|December 1, 1977
Effect of a human serum thymic factor on hydrocortisone-treated thymocytesG C Astaldi, A Astaldi, M Groenewoud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1977
Thymosin-induced human serum factor increasing cyclic AMPA Astaldi, G C Astaldi, P Wijermans, et al.
British Journal of Haematology|September 1, 2001
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidineM Lübbert, P Wijermans, R Kunzmann, et al.
Leukemia & Lymphoma|August 1, 1995
Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomasK Fenchel, L Bergmann, P Wijermans, et al.
Cancer Treatment Reports|November 1, 1978
Experiences with thymosin in primary immunodeficiency diseaseA Astaldi, G C Astaldi, P Wijermans, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Future Oncology (London, England)|March 25, 2006
Epigenetic therapy with decitabine for myelodysplasia and leukemiaP Wijermans, M Lübert
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1980
Influence of adult thymectomy on immunocompetence in patients with myasthenia gravisP Wijermans, H J Oosterhuis, G C Astaldi, et al.
The Netherlands Journal of Medicine|March 7, 2013
A survey on diagnostic methods and treatment strategies used in patients with Waldenström's macroglobulinaemia in The NetherlandsS Klodzinska, J M I Vos, M J Kersten, et al.
Clinical and Experimental Immunology|January 1, 1983
Low beta-adrenergic receptor concentration on human thymocytesR J van de Griend, A Astaldi, P Wijermans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patientsP Wijermans, M Lübbert, G Verhoef, et al.
European Journal of Immunology|December 1, 1977
Effect of a human serum thymic factor on hydrocortisone-treated thymocytesG C Astaldi, A Astaldi, M Groenewoud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1977
Thymosin-induced human serum factor increasing cyclic AMPA Astaldi, G C Astaldi, P Wijermans, et al.
British Journal of Haematology|September 1, 2001
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidineM Lübbert, P Wijermans, R Kunzmann, et al.
Leukemia & Lymphoma|August 1, 1995
Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomasK Fenchel, L Bergmann, P Wijermans, et al.
Cancer Treatment Reports|November 1, 1978
Experiences with thymosin in primary immunodeficiency diseaseA Astaldi, G C Astaldi, P Wijermans, et al.
Pageof 3